Session Details

[28-12-am]Clinical Pharmacy 7, Cancer/Personalizaed therapies

Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 12 (C403, Bldg. 2, Area 2 [4F])
Chair: Hideo Kato, Sumio Matzno

[28-12-am01S]Relationship between C-reactive Protein kinetics and Prognosis in Patients with Non–Small Cell Lung Cancer Receiving Osimertinib

○Ayaka Kobayashi1,2, Miki Sato1, Saeko Kashimura3, Ryo Manabe4, Sojiro Kusumoto4, Akihiko Tanaka4, Mari Kogo1 (1. Showa Med. Univ. Grad. Sch. Pharm., 2. Pharm, Showa Med. Univ. Northern Yokohama Hospital., 3. Pharm., Showa Med. Univ. Koto Toyosu Hospital., 4. Division of Respiratory Medicine and Allergology, Showa Med. Univ. Hospital)

[28-12-am02S]Factors Affecting Hyperuricemia Induced by Tumor Lysis Syndrome after Induction Therapy in Pediatric Acute Lymphoblastic Leukemia Using a Claims Database

○Miki Ueno1, Shungo Imai1, Masami Tsuchiya1, Keisuke Ikegami1, Hayato Kizaki1, Satoko Hori1 (1. Keio univ. Pharm.)

[28-12-am03S]Induction of Ferroptosis in Glioblastoma Cells via Disruption of Antioxidant Defense through Dual Inhibition of GGCT and xCT

○Masaya Mori1, Yuhi Sone1, Nanami Nihei1, Kozue Nose1, Mitsugu Fujita2, Takahiro Matsumoto3, Hiromi Ii1, Susumu Nakata1 (1. Lab. of Clinical Oncology, Kyoto Pharm. Univ, 2. Faculty of Med, Kindai Univ, 3. Lab. of Public Health, Kyoto Pharm. Univ)

[28-12-am04]Evaluation of Cancer Microenvironment Normalization by Meflin mRNA Delivery to Cancer Associated Fibroblasts

○Hideyuki Masuda1, Yuichi Yamasaki1 (1. Musashino Univ.)

[28-12-am05S]Elucidation of the molecular mechanisms of drug-tolerant persister cells in non-small cell lung cancer by single-cell derived clones

○Mo Zhou1, Yuya Haga1,2, Kazuma Higashisaka1,2,3, Yasuo Tsutsumi1,2,4,5,6,7 (1. Grad. Sch. Pharm. Sci., UOsaka, 2. Sch. Pharm. Sci., UOsaka, 3. IACS, UOsaka, 4. MEI Ctr., UOsaka, 5. OTRI, UOsaka, 6. INSD, UOsaka, 7. Grad. Sch. Med., UOsaka)

[28-12-am06S]Analysis of anoikis resistant-related molecules in breast cancer stem cell models

○Asahi Sami1, Kyoka Hashimoto1, Matsuri Matsuoka1, Karin Matsumoto1, Aina Tsujihana2, Rei Takahashi1,3, Kiyotsugu Yoshikawa1 (1. Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, 2. Graduate School of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, 3. Advanced Pathology Institute API)

[28-12-am07S]Elucidating the mechanism of activation of anti-tumor immunity via STING signaling by oncolytic adenovirus based on serotype 35

○Hayato Nakatani1, Masashi Tachibana1,2, Sora Tokuoka3, Takato Nakagaki3, Kahori Shimizu1,3, Fuminori Sakurai1,4, Hiroyuki Mizuguchi1,3,5,6,7,8 (1. Grad. Sch. Pharm. Sci, Univ. Osaka., 2. Col Life Sci, Ritsumeikan Univ., 3. Sch. Pharm. Sci, Univ. Osaka., 4. Fac. Pharm., Kindai Univ., 5. Natl. Inst. Biomed. Innov. Health Nutr., 6. MEIC, Univ. Osaka., 7. OTRI, Univ. Osaka., 8. CiDER, Univ. Osaka.)

[28-12-am08S]Identification of Genes Associated with Ferroptosis Resistance in the Adipogenic State of Mesenchymal Breast Cancer Cells

○Aina Tsujihana1,2, Ukina Isomoto1, Momoko Kashiwagi1, Matsuri Matsuoka1, Karin Matsumoto1, Asahi sami1, Chiaki Doi1, Satomi Nakamura1, Natsu Miura1, Sana Nakazawa1, Saki Nishimura1, Nonoka Sakurai1, Mai Shibata1, Kanako Takeda1, Rinna Yamaguchi1, Rei Takahashi1,3, Kiyotsugu Yoshikawa1 (1. Doshisha Women's College of Liberal Arts, 2. Graduate School of Pharmaceutical Sciences Doshisha Women's College of Liberal Arts, 3. Advanced Pathology Institute)

[28-12-am09S]Reovirus-induced PGE2 production and its role in reovirus-resistance in cancer cells

○Ayaka Ihara1, Hiroaki Shimada1, Ikuho Ishigami2, Yuki Nisawa1, Atsushi Kawase1, Hiroyuki Mizuguchi2,3,4,5, Fuminori Sakurai1,2 (1. Fac. Pharm., Kindai Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. NIBN, 4. Int. Med. Eng.Inform., Osaka Univ, 5. OTRI)

[28-12-am10]Retrospective study of the effect of urinary pH on the development of vancomycin-associated acute kidney injury

○Masayuki Ishikawa1,2, Masashi Uchida1,2, Shingo Yamazaki1,2, Itsuko Ishii1,2 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Div. of Pharm., Chiba Univ. Hosp.)